Work

Phase I clinical trials of intravenous 2′-deoxycytidine-2′-fluoromethylene (FMdC) in patients with advanced solid tumors

Year: 1999

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(99)81601-3

Authors: G.I. Rodriquez, D.J. Brooks, B.A. Burtness

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2047820231

FWCI:

Cites:

Cited by:

Related to: 10